English
RPG Life Sciences Q2 Results
- BSE: 532983
- NSE: RPGLIFE
- ISIN: INE105J01010
- Sector: Biotechnology & Drugs
BSE
2,228.80
28.05 (1.27%)
28.05 (1.27%)Volume64.00
Updated: Fri 5 Dec, 2025 | 15:29:10
NSE
2,198.00
-10.30 (-0.47%)
-10.30 (-0.47%)Volume4.55 K
Updated: Fri 5 Dec, 2025 | 15:29:56
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
- Total Income₹181.68 Cr.(5.50%)
- Operating Profit₹45.03 Cr.(238.06%)
- Profit After Tax₹36.85 Cr.(777.38%)
- Operating Margin24.79%(220.44%)
Note: Comparison is on YoY basis
Quarterly - RPG Life Sciences Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 25 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 136.65 | 138.59 | -1.40% | 158.89 | -14.00% |
| Depreciation/ Amortization | 5.22 | 5.14 | 1.56% | 5.31 | -1.69% |
| Operating Income | 45.03 | 30.33 | 48.47% | 13.32 | 238.06% |
| Net Income | 36.85 | 26.29 | 40.17% | 4.20 | 777.38% |
| Other Operating Expenses Total | 39.91 | 39.73 | 0.45% | 39.02 | 2.28% |
| Net Income Before Taxes | 49.45 | 35.43 | 39.57% | 15.09 | 227.70% |
| Total Revenue | 181.68 | 168.92 | 7.55% | 172.21 | 5.50% |
| Selling/ General/ Admin Expenses Total | 36.16 | 33.70 | 7.30% | 33.09 | 9.28% |
| Diluted Normalized EPS | 17.22 | 15.90 | 8.33% | 13.27 | 29.79% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.